Alpha-Agonist
Sponsors
General Hospital of Ningxia Medical University
Conditions
Adverse EffectOutcome
Unknown Phase
Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients
NCT06151444
Start: 2024-07-01End: 2024-12-31Target: 160Updated: 2023-11-30
90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment
NCT06151522
Start: 2025-04-01End: 2025-06-30Target: 80Updated: 2023-11-30
90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients
NCT06151457
Start: 2025-01-01End: 2025-06-30Target: 80Updated: 2023-11-30
90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment
NCT06151509
Start: 2025-01-01End: 2025-03-31Target: 80Updated: 2023-11-30
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics
NCT06151496
Start: 2024-12-01End: 2025-12-31Target: 300Updated: 2023-11-30
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension
CompletedNCT06151483
Start: 2023-12-01End: 2024-08-19Updated: 2024-08-21
90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients
NCT06151470
Start: 2025-07-01End: 2025-12-31Target: 80Updated: 2023-11-30
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension in Preeclamptic Patients
CompletedNCT06151431
Start: 2023-12-05End: 2026-03-21Updated: 2026-04-30